Total Voting Rights

RNS Number : 6319T

Hutchison China Meditech Limited

31 March 2016

 

Total Voting Rights

London: Thursday, March 31, 2016: For information purposes, Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) hereby notifies the market that as at March 31, 2016, the issued share capital of Chi-Med consisted of 60,283,118 ordinary shares of US$1.00 each, with each share carrying one right to vote and with no shares held in treasury.

The above figure of 60,283,118 may be used by shareholders as the denominator for the calculations by which they could determine if they are required to notify their interest in, or a change to their interest in, Chi-Med under the Financial Conduct Authority's Disclosure Rules and Transparency Rules.

Ends

Contact

Investor Enquiries
Christian Hogg, CEO	[phone]
International Media Enquiries
Anthony Carlisle, Citigate Dewe Rogerson	[phone] (Mobile)
US Based Media Enquiries
Brad Miles, BMC Communications	[phone]
Susan Duffy, BMC Communications	[phone]
Investor Relations
Jillian Connell, The Trout Group	[phone]
David Dible, Citigate Dewe Rogerson	[phone] [phone] (Mobile)
Panmure Gordon (UK) Limited
Richard Gray / Andrew Potts	[phone]

Notes to Editors

About Chi-Med

Chi-Med is a China-based, globally-focused healthcare group which researches, develops, manufactures and sells pharmaceuticals and health-related consumer products.  Its Innovation Platform focuses on discovering and developing innovative therapeutics in oncology and autoimmune diseases for the global market.  Its Commercial Platform manufactures, markets and distributes prescription drugs and consumer health products in China.

Chi-Med is majority owned by the multinational conglomerate CK Hutchison Holdings Limited (SEHK: 0001).  For more information, please visit: www.chi-med.com.

 

END

 

 

TVREALDFDLFKEEF